Sponsor content

Treating neurodegenerative diseases with stem cell therapy

Brainstorm Cell Therapeutics is looking for financial and corporate partners to help complete the development and launch of revolutionary neurodegenerative disease treatments.

Upvote 1 Comment
Page of
Go to the profile of BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

No comments yet.